Dick Menzies

Q: What Schools Are Affiliated With Dick Menzies

Dick Menzies is affiliated with the following schools: McGill University, University of British Columbia

Dick Menzies's AcademicInfluence.com Rankings

Dick Menzies

Philosophy

#5156

World Rank

#7887

Historical Rank

Logic

#2480

World Rank

#3479

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Dick Menzies's Degrees

Masters Public Health University of British Columbia
Bachelors Biology McGill University

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Dick Menzies Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Dick Menzies's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Systematic Review: T-Cellbased Assays for the Diagnosis of Latent Tuberculosis Infection: An Update (2008) (1376)
Meta-analysis: New Tests for the Diagnosis of Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for Research (2007) (1079)
Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. (2003) (792)
Three months of rifapentine and isoniazid for latent tuberculosis infection. (2011) (772)
Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis (2020) (685)
False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? (2006) (635)
Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case–control studies (2004) (599)
Tuberculosis among Health-Care Workers in Low- and Middle-Income Countries: A Systematic Review (2006) (548)
Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients (2012) (522)
Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients (2012) (522)
Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. (1999) (520)
The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices (2011) (513)
Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. (2012) (479)
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries (2015) (477)
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice (2010) (450)
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. (2017) (447)
Risk of tuberculosis infection and disease associated with work in health care settings. (2007) (431)
Systematic reviews and meta-analyses. (2011) (407)
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis (2018) (358)
Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes (2012) (348)
The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. (2016) (295)
Tuberculosis among health care workers. (1995) (284)
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement (2014) (279)
Serial testing of health care workers for tuberculosis using interferon-γ assay (2006) (259)
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis. (2009) (256)
Commercial Serological Antibody Detection Tests for the Diagnosis of Pulmonary Tuberculosis: A Systematic Review (2007) (253)
Adverse reactions to first-line antituberculosis drugs (2006) (245)
Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children: a systematic review and meta-analysis. (2015) (239)
Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review (2011) (239)
Heterogeneous Antibody Responses in Tuberculosis (1998) (239)
Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. (2011) (229)
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults (2018) (228)
Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: A systematic review and meta-analysis (2020) (224)
Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis (2012) (222)
Hospital Ventilation and Risk for Tuberculous Infection in Canadian Health Care Workers (2000) (219)
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline (2019) (216)
Adverse Events with 4 Months of Rifampin Therapy or 9 Months of Isoniazid Therapy for Latent Tuberculosis Infection (2008) (214)
Delay in diagnosis among hospitalized patients with active tuberculosis--predictors and outcomes. (2002) (214)
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study (2021) (201)
Effect of Duration and Intermittency of Rifampin on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis (2009) (200)
Standardized Treatment of Active Tuberculosis in Patients with Previous Treatment and/or with Mono-resistance to Isoniazid: A Systematic Review and Meta-analysis (2009) (193)
Initial Drug Resistance and Tuberculosis Treatment Outcomes: Systematic Review and Meta-analysis (2008) (192)
Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis (2011) (189)
Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020 (2020) (189)
Treatment of latent tuberculosis infection: An update (2010) (187)
What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us? (2000) (185)
Serial testing of health care workers for tuberculosis using interferon-gamma assay. (2006) (183)
Major Mycobacterium tuberculosis Lineages Associate with Patient Country of Origin (2009) (180)
Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis. (2010) (175)
Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis. (2017) (171)
Treatment completion and costs of a randomized trial of rifampin for 4 months versus isoniazid for 9 months. (2004) (167)
Cost-effectiveness of tuberculosis control strategies among immigrants and refugees (2005) (164)
Novel tests for diagnosing tuberculous pleural effusion: what works and what does not? (2008) (163)
A systematic review of commercial serological antibody detection tests for the diagnosis of extrapulmonary tuberculosis (2007) (161)
Comparison of sputum induction with fiber-optic bronchoscopy in the diagnosis of tuberculosis. (1995) (147)
T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. (2009) (145)
Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis. (2010) (144)
Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations. (2000) (142)
Nutritional Status of Adult Patients with Pulmonary Tuberculosis in Rural Central India and Its Association with Mortality (2013) (136)
Effect of ultraviolet germicidal lights installed in office ventilation systems on workers' health and wellbeing: double-blind multiple crossover trial (2003) (132)
Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence (2013) (132)
Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis. (2007) (130)
The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs (2021) (128)
Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis. (2000) (122)
Antibody Profiles Characteristic of Mycobacterium tuberculosis Infection State (2005) (122)
Building-related illnesses. (1997) (117)
Quality of tuberculosis care in India: a systematic review. (2015) (114)
Domestic returns from investment in the control of tuberculosis in other countries. (2005) (113)
Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis. (2014) (111)
IFN-gamma and IL-12 are increased in active compared with inactive tuberculosis. (1997) (111)
T-Cell Assays for Tuberculosis Infection: Deriving Cut-Offs for Conversions Using Reproducibility Data (2008) (110)
Factors associated with humoral response to ESAT-6, 38 kDa and 14 kDa in patients with a spectrum of tuberculosis. (2003) (107)
Tuberculosis: evidence review for newly arriving immigrants and refugees (2011) (105)
Safety and Side Effects of Rifampin versus Isoniazid in Children (2018) (105)
Agreement in measuring socio-economic status: area-based versus individual measures. (2000) (102)
Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis. (2020) (102)
Yield of smear, culture and amplification tests from repeated sputum induction for the diagnosis of pulmonary tuberculosis. (2001) (101)
Accuracy and utility of commercially available amplification and serologic tests for the diagnosis of minimal pulmonary tuberculosis. (2000) (95)
A Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant Tuberculosis (2013) (94)
Thinking in three dimensions: a web-based algorithm to aid the interpretation of tuberculin skin test results. (2008) (92)
Cost of tuberculosis diagnosis and treatment from the patient perspective in Lusaka, Zambia. (2008) (91)
Long-term impact of bronchopulmonary dysplasia on pulmonary function. (2011) (90)
Interferon-γ Release Assays: What Is Their Role in the Diagnosis of Active Tuberculosis? (2007) (88)
A systematic review of the diagnostic accuracy of artificial intelligence-based computer programs to analyze chest x-rays for pulmonary tuberculosis (2019) (88)
Xpert MTB/RIF testing in a low tuberculosis incidence, high-resource setting: limitations in accuracy and clinical impact. (2014) (88)
Patients' Costs and Cost-Effectiveness of Tuberculosis Treatment in DOTS and Non-DOTS Facilities in Rio de Janeiro, Brazil (2010) (86)
Fixed-dose combination antituberculosis therapy: a systematic review and meta-analysis (2013) (84)
Tuberculosis infection among health care workers in Montreal. (1996) (82)
Recent developments in treatment of latent tuberculosis infection (2011) (82)
Influence of multidrug resistance on tuberculosis treatment outcomes with standardized regimens. (2008) (81)
Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses (2017) (78)
Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis (2018) (77)
Preventive chemotherapy. Where has it got us? Where to go next? (2008) (76)
The impact of the Brazilian family health on selected primary care sensitive conditions: A systematic review (2017) (75)
A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury. (2019) (75)
Does size matter? Utility of size of tuberculin reactions for the diagnosis of mycobacterial disease. (2000) (74)
Undernutrition and the incidence of tuberculosis in India: national and subnational estimates of the population-attributable fraction related to undernutrition. (2014) (74)
Dwellings, crowding, and tuberculosis in Montreal. (2006) (72)
An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis (2017) (72)
Repeat IGRA Testing in Canadian Health Workers: Conversions or Unexplained Variability? (2013) (72)
Incidence of ethambutol-related visual impairment during treatment of active tuberculosis. (2013) (71)
Validity of asthma diagnoses recorded in the Medical Services database of Quebec (2006) (70)
Feasibility and reliability of health-related quality of life measurements among tuberculosis patients (2004) (70)
The new IGRA and the old TST: making good use of disagreement. (2007) (70)
Therapeutic drug monitoring in the treatment of active tuberculosis. (2011) (70)
Global tuberculosis trends: a reflection of changes in tuberculosis control or in population health? (2009) (70)
Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis. (2018) (70)
Reduced Transmissibility of East African Indian Strains of Mycobacterium tuberculosis (2011) (69)
Increased expression of IL-12 receptor mRNA in active pulmonary tuberculosis and sarcoidosis. (1999) (68)
Population genomics of Mycobacterium tuberculosis in the Inuit (2015) (68)
Risk of lung cancer following nonmalignant respiratory conditions: evidence from two case-control studies in Montreal, Canada. (2006) (68)
Interferon-gamma release assays: what is their role in the diagnosis of active tuberculosis? (2007) (67)
Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass. (2005) (67)
An updated systematic review and meta-analysis on the treatment of active tuberculosis in patients with HIV infection. (2012) (67)
Reemergence and amplification of tuberculosis in the Canadian arctic. (2015) (66)
Sensitivities and Specificities of Spoligotyping and Mycobacterial Interspersed Repetitive Unit-Variable-Number Tandem Repeat Typing Methods for Studying Molecular Epidemiology of Tuberculosis (2005) (65)
Effect of sample handling on analysis of cytokine responses to Mycobacterium tuberculosis in clinical samples using ELISA, ELISPOT and quantitative PCR. (2005) (64)
Socioeconomic status and lung function among primary school children in Canada. (1996) (63)
Fatores associados ao atraso no diagnóstico da tuberculose pulmonar no estado do Rio de Janeiro (2011) (62)
Nosocomial Tuberculosis in India (2006) (62)
Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions (2016) (61)
Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data Metaanalysis. (2016) (61)
Effect of a new ventilation system on health and well-being of office workers. (1997) (61)
Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data Metaanalysis. (2016) (61)
Impact of treatment completion, intolerance and adverse events on health system costs in a randomised trial of 4 months rifampin or 9 months isoniazid for latent TB (2010) (57)
Chest radiograph abnormalities associated with tuberculosis: reproducibility and yield of active cases. (2002) (56)
Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment. (2010) (56)
Yield of tuberculin screening among injection drug users. (2004) (55)
Latent tuberculosis infection among undergraduate medical students in Rio de Janeiro State, Brazil. (2005) (54)
Aeroallergens and work-related respiratory symptoms among office workers. (1998) (54)
Scoring systems using chest radiographic features for the diagnosis of pulmonary tuberculosis in adults: a systematic review (2012) (53)
Gamma Interferon Release Assay for Monitoring of Treatment Response for Active Tuberculosis: an Explosion in the Spaghetti Factory (2012) (52)
Effect of Treatment on Contagiousness of Patients With Active Pulmonary Tuberculosis (1997) (51)
Saudi guidelines for testing and treatment of latent tuberculosis infection (2010) (50)
Microcolony culture techniques for tuberculosis diagnosis: a systematic review. (2012) (50)
Cost-Effectiveness of Quantiferon®-TB Gold-In-Tube Versus Tuberculin Skin Testing for Contact Screening and Treatment of Latent Tuberculosis Infection in Brazil (2013) (48)
Germicidal ultraviolet irradiation in air conditioning systems: effect on office worker health and wellbeing: a pilot study. (1999) (48)
Use of geographic and genotyping tools to characterise tuberculosis transmission in Montreal. (2007) (48)
Costs for tuberculosis care in Canada. (2008) (48)
Discordance between tuberculin skin test and interferon-gamma assays. (2006) (48)
Comparison of LED and Conventional Fluorescence Microscopy for Detection of Acid Fast Bacilli in a Low-Incidence Setting (2011) (48)
Adverse events associated with treatment of latent tuberculosis in the general population (2011) (48)
Prevalence of Abnormal Radiological Findings in Health Care Workers with Latent Tuberculosis Infection and Correlations with T Cell Immune Response (2007) (46)
Development of a Simple Reliable Radiographic Scoring System to Aid the Diagnosis of Pulmonary Tuberculosis (2013) (46)
Molecular epidemiology of tuberculosis in Montreal. (2002) (45)
Intestinal dysbiosis compromises alveolar macrophage immunity to Mycobacterium tuberculosis (2019) (45)
Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis (2020) (43)
Chest x-ray analysis with deep learning-based software as a triage test for pulmonary tuberculosis: a prospective study of diagnostic accuracy for culture-confirmed disease. (2020) (43)
Patient and family costs associated with tuberculosis, including multidrug-resistant tuberculosis, in Ecuador. (2010) (42)
Emergence of drug resistance in patients with tuberculosis cared for by the Indian health-care system: a dynamic modelling study. (2017) (42)
Risk of Active Tuberculosis in Patients with Cancer: A Systematic Review and Meta-Analysis. (2017) (42)
Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatment (2015) (42)
Invasive aspergillosis in patients with chronic obstructive pulmonary diseases. (2005) (41)
Issues in the management of contacts of patients with active pulmonary tuberculosis. (1997) (40)
Costs incurred by patients with pulmonary tuberculosis in rural India. (2009) (40)
Genomic Characterization of an Endemic Mycobacterium tuberculosis Strain: Evolutionary and Epidemiologic Implications (2004) (40)
Direct and indirect costs of tuberculosis among immigrant patients in the Netherlands (2009) (40)
Latent tuberculosis infection in healthcare workers in low- and middle-income countries: an updated systematic review (2019) (40)
Re-evaluation of acid-base prediction rules in patients with chronic respiratory acidosis. (2003) (39)
Risk of Active Tuberculosis in Patients With Cancer: A Systematic Review and Metaanalysis (2016) (38)
Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis (2019) (38)
Can social interventions prevent tuberculosis?: the Papworth experiment (1918-1943) revisited. (2012) (38)
TB Screening in Canadian Health Care Workers Using Interferon-Gamma Release Assays (2012) (37)
Patients with HIV Infection (2012) (37)
Humoral response to Mycobacterium tuberculosis antigens in patients with tuberculosis in the Gambia. (2005) (37)
Occurrence and severity of bronchopulmonary dysplasia and respiratory distress syndrome after a preterm birth. (2011) (36)
A cohort study showed that health insurance databases were accurate to distinguish chronic obstructive pulmonary disease from asthma and classify disease severity. (2005) (36)
Measurement of Health Preferences among Patients with Tuberculous Infection and Disease (2002) (35)
Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials. (2019) (35)
Interventions to improve retention-in-care and treatment adherence among patients with drug-resistant tuberculosis: a systematic review (2018) (35)
Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis (2020) (34)
How Methodologic Differences Affect Results of Economic Analyses: A Systematic Review of Interferon Gamma Release Assays for the Diagnosis of LTBI (2013) (34)
Using Tests for Latent Tuberculous Infection to Diagnose Active Tuberculosis: Can We Eat Our Cake and Have It Too? (2008) (34)
Factors associated with tuberculin conversion in Canadian microbiology and pathology workers. (2003) (34)
Knowledge and practices of medical students to prevent tuberculosis transmission in Rio de Janeiro, Brazil. (2008) (33)
Factors associated with delayed diagnosis of pulmonary tuberculosis in the state of Rio de Janeiro, Brazil. (2011) (33)
Predicting tuberculosis relapse in patients treated with the standard 6-month regimen: an individual patient data meta-analysis (2018) (33)
Health-related quality of life and tuberculosis: a longitudinal cohort study (2015) (32)
Impact of DOTS expansion on tuberculosis related outcomes and costs in Haiti (2006) (32)
Tuberculosis and homelessness in Montreal: a retrospective cohort study (2011) (32)
Tuberculosis: 11. Nosocomial disease. (1999) (32)
Screening immigrants to Canada for tuberculosis: chest radiography or tuberculin skin testing? (2003) (31)
Impact of immigration on tuberculosis infection among Canadian-born schoolchildren and young adults in Montreal. (1997) (31)
Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study (2011) (31)
Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method (2016) (30)
Predicting tuberculosis: does the IGRA tell the tale? (2008) (30)
Update in tuberculosis and nontuberculous mycobacterial disease 2011. (2012) (30)
Tuberculosis: 10. Prevention. (1999) (30)
Latent tuberculous infection in household contacts of multidrug-resistant and newly diagnosed tuberculosis. (2017) (30)
Epidemiology of tuberculosis immunology. (2013) (29)
Risk factors for latent tuberculosis infection in close contacts of active tuberculosis patients in South Korea: a prospective cohort study (2013) (29)
Marked disparity in the epidemiology of tuberculosis among Aboriginal peoples on the Canadian prairies: the challenges and opportunities. (2013) (28)
Transmission of Mycobacterium tuberculosis Beijing Strains, Alberta, Canada, 1991–2007 (2013) (28)
Tuberculosis in health care workers: a multicentre Canadian prevalence survey: preliminary results. Canadian Collaborative Group in Nosocomial Transmission of Tuberculosis. (1998) (28)
The impact and cost-effectiveness of strategies to detect drug-resistant tuberculosis (2011) (28)
Update in tuberculosis and nontuberculous mycobacterial disease 2012. (2013) (28)
In closely monitored patients, adherence in the first month predicts completion of therapy for latent tuberculosis infection. (2005) (28)
Tuberculosis in association with travel. (2003) (27)
Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis [Review article]. (2011) (26)
Widespread Pyrazinamide-Resistant Mycobacterium tuberculosis Family in a Low-Incidence Setting (2003) (26)
Effect of Intermittency on Treatment Outcomes in Pulmonary Tuberculosis: An Updated Systematic Review and Metaanalysis (2017) (26)
Fluoroquinolone Therapy for the Prevention of Multidrug-Resistant Tuberculosis in Contacts. A Cost-Effectiveness Analysis. (2015) (26)
Prevalence of tuberculin skin test reactions among prison workers. (1997) (26)
Knowledge and Perceptions of Tuberculosis Among a Sample of Urban Aboriginal People (2008) (26)
Tuberculosis crosses borders. (2000) (25)
Active testing of groups at increased risk of acquiring SARS-CoV-2 in Canada: costs and human resource needs (2020) (24)
Evaluating the role of primary care physicians in the treatment of latent tuberculosis: a population study. (2014) (24)
Controlling tuberculosis among foreign born within industrialized countries: expensive band-aids. (2001) (23)
Knowledge about tuberculosis transmission and prevention and perceptions of health service utilization among index cases and contacts in Brazil: Understanding losses in the latent tuberculosis cascade of care (2017) (23)
Progression to tuberculosis disease increases with multiple exposures (2016) (23)
Autotransfusion of shed mediastinal blood: a risk factor for mediastinitis after cardiac surgery? Results of a cluster investigation. (2003) (23)
Health care utilization by preterm infants with respiratory complications in Quebec. (2012) (22)
Group 5 drugs for multidrug-resistant tuberculosis: individual patient data meta-analysis (2017) (22)
Treatment with isoniazid or rifampin for latent tuberculosis infection: population-based study of hepatotoxicity, completion and costs (2020) (22)
Inadequate Diet Is Associated with Acquiring Mycobacterium tuberculosis Infection in an Inuit Community. A Case-Control Study. (2015) (21)
Tuberculosis surveillance among new immigrants in Montreal. (2005) (21)
Clinical outcomes of pyrazinamide-monoresistant Mycobacterium tuberculosis in Quebec. (2012) (21)
Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial (2020) (21)
Treatment of human disease due to Mycobacterium bovis: a systematic review (2016) (21)
Clinical standards for the diagnosis, treatment and prevention of TB infection (2022) (20)
Diagnosis of Latent Tuberculosis Infection (2006) (20)
Efficacy of Environmental Measures in Reducing Potentially Infectious Bioaerosols During Sputum Induction (2003) (20)
Effectiveness of Canada's tuberculosis surveillance strategy in identifying immigrants at risk of developing and transmitting tuberculosis: a population-based retrospective cohort study. (2017) (20)
Tuberculosis screening of travelers to higher-incidence countries: A cost-effectiveness analysis (2008) (20)
Sputum induction: simpler, cheaper, and safer--but is it better? (2003) (20)
Point-of-Care Urine Tests for Smoking Status and Isoniazid Treatment Monitoring in Adult Patients (2012) (20)
Determinants of tuberculosis trends in six Indigenous populations of the USA, Canada, and Greenland from 1960 to 2014: a population-based study. (2018) (20)
Occupational respiratory infections (2010) (19)
Validation of ICD-9 diagnostic codes for bronchopulmonary dysplasia in Quebec's provincial health care databases. (2012) (19)
Correction: Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients (2012) (19)
Is screening immigrants for latent tuberculosis cost-effective? (2011) (18)
Analysis of loss to follow-up in 4099 multidrug-resistant pulmonary tuberculosis patients (2019) (18)
Diversity of Mycobacterium tuberculosis isolates in an immigrant population: evidence against a founder effect. (2004) (17)
Two-step tuberculin skin test and booster phenomenon prevalence among Brazilian medical students. (2008) (17)
Interventions to reduce losses in the cascade of care for latent tuberculosis: a systematic review and meta-analysis. (2020) (17)
Treatment of drug-resistant tuberculosis (2011) (17)
Trajectories of tuberculosis-specific interferon-gamma release assay responses among medical and nursing students in rural India (2013) (17)
Guidelines for the treatment of latent tuberculosis infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020 (2020) (17)
Comparing cost-effectiveness of standardised tuberculosis treatments given varying drug resistance (2013) (17)
Canadian Tuberculosis Standards (2014) (16)
Fading of Auramine-Stained Mycobacterial Smears and Implications for External Quality Assurance (2011) (16)
Enhancing the public health impact of latent tuberculosis infection diagnosis and treatment (ACT4): protocol for a cluster randomised trial (2019) (16)
Housing and tuberculosis in an Inuit village in northern Quebec: a case-control study. (2016) (16)
Non-completion of latent tuberculous infection treatment among children in Rio de Janeiro State, Brazil. (2016) (16)
Predictors of hospitalization of tuberculosis patients in Montreal, Canada: a retrospective cohort study (2016) (16)
Correction: The impact of the Brazilian family health on selected primary care sensitive conditions: A systematic review (2017) (15)
Drug-Resistant Tuberculosis (2011) (15)
Health System Costs of Treating Latent Tuberculosis Infection With Four Months of Rifampin Versus Nine Months of Isoniazid in Different Settings (2020) (15)
The use of environmental factors as adjuncts to traditional tuberculosis contact investigation. (2006) (15)
Medical students at risk of nosocomial tuberculosis. (2011) (15)
Patient characteristics associated with failure of tuberculosis prevention. (1996) (14)
Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review (2020) (14)
How close is close enough? Exploring matching criteria in the estimation of recent transmission of tuberculosis. (2009) (14)
Disrupting a cycle of mistrust: A constructivist grounded theory study on patient-provider trust in TB care. (2019) (13)
DOTS implementation in a middle-income country: development and evaluation of a novel approach. (2005) (13)
Causal inference with multiple concurrent medications: A comparison of methods and an application in multidrug-resistant tuberculosis (2018) (13)
The utility and interpretation of tuberculin skin tests in the Middle East. (2005) (13)
Predicting outcomes and drug resistance with standardised treatment of active tuberculosis (2010) (13)
Comparing the Diagnostic Performance of QFT-Plus to Other Tests of Latent Tuberculosis Infection: A Systematic Review and Meta-analysis. (2020) (13)
Aminoglycosides and Capreomycin in the Treatment of Multidrug-resistant Tuberculosis: Individual Patient Data Meta-analysis of 12 030 Patients From 25 Countries, 2009-2016. (2020) (13)
Developing a Tuberculosis Transmission Model That Accounts for Changes in Population Health (2011) (13)
Costs for Tuberculosis Care in Canada (2008) (12)
Effectiveness Of Post-Arrival Latent Tuberculosis Screening Programs In The Foreign Born: A Systematic Review And Meta-Analysis (2012) (12)
Potential cost-effectiveness of rifampin vs. isoniazid for latent tuberculosis: implications for future clinical trials. (2011) (12)
Framework for the evaluation of new tests for tuberculosis infection (2021) (12)
Knowledge, attitudes and practices on tuberculosis transmission and prevention among auxiliary healthcare professionals in three Brazilian high-burden cities: a cross-sectional survey (2019) (12)
Changes in QuantiFERON®-TB Gold In-Tube results during treatment for tuberculous infection. (2013) (12)
The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis (2021) (12)
Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis (2021) (11)
Tuberculosis in health care workers: a multicentre Canadian prevalence survey: preliminary results [The George Comstock Lecture]. (1998) (11)
A Population-Based Cohort Study of Mycobacterium tuberculosis Beijing Strains: An Emerging Public Health Threat in an Immigrant-Receiving Country? (2012) (11)
Association Between Bacillus Calmette-Guérin Vaccination and Childhood Asthma in the Quebec Birth Cohort on Immunity and Health (2017) (11)
Yield of casual contact investigation by the hour. (2003) (11)
Tuberculosis transmission in the Indigenous peoples of the Canadian prairies (2017) (11)
Determinants of Bacillus Calmette-Guérin (BCG) vaccination among Québec children. (2014) (11)
Evaluation of the Impact of Interferon-Gamma Release Assays on the Management of Childhood Tuberculosis (2012) (11)
Propensity Score-Based Approaches to Confounding by Indication in Individual Patient Data Meta-Analysis: Non-Standardized Treatment for Multidrug Resistant Tuberculosis (2016) (10)
Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis (2021) (10)
The impact of tuberculosis on health utility: a longitudinal cohort study (2015) (10)
Is there a role for mask continuous positive airway pressure in acute respiratory failure due to COPD? Lessons from a retrospective audit of 3 different cohorts (2006) (10)
Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis (2020) (10)
Modeling the impact of tuberculosis interventions on epidemiologic outcomes and health system costs (2015) (10)
False-positive tuberculin reactions due to non-tuberculous mycobacterial infections. (2007) (10)
Tuberculin surveys--why? (1998) (10)
The Long-term Health and Economic Benefits of DOTS Implementation in Ecuador (2006) (9)
Resource implications of the latent tuberculosis cascade of care: a time and motion study in five countries (2020) (9)
Serial interferon-gamma release assays for latent tuberculosis in dialysis patients with end stage renal disease in a Korean population (2015) (9)
Is there a fundamental flaw in Canada’s post-arrival immigrant surveillance system for tuberculosis? (2019) (9)
Bacillus Calmette-Guérin (BCG) vaccination patterns in the province of Québec, Canada, 1956-1974. (2017) (9)
Safety and Efficacy of Rifampin or Isoniazid Among People with Mycobacterium tuberculosis Infection and Living with HIV or Other Health Conditions: Post-Hoc Analysis of Two Randomized Trials. (2020) (9)
Effectiveness and cost-effectiveness of a health systems intervention for latent tuberculosis infection management (ACT4): a cluster-randomised trial. (2021) (9)
The impact of improved detection and treatment of isoniazid resistant tuberculosis on prevalence of multi-drug resistant tuberculosis: A modelling study (2019) (9)
Conversions and Reversions in Health Care Workers in Montreal, Canada Using QuantiFERON-TB-Gold In-Tube. (2009) (9)
Challenges to Tuberculin Screening and Follow-up in an Urban Aboriginal Sample in Montreal, Canada (2008) (8)
Chapter 5: Treatment of tuberculosis disease (2022) (8)
Treatment of Mycobacterium tuberculosis Infection: Time to Get a Move On? (2014) (8)
Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study (2022) (8)
Evidence-based Definition for Extensively Drug-resistant Tuberculosis. (2021) (8)
A prospective cohort study of latent tuberculosis in adult close contacts of active pulmonary tuberculosis patients in Korea (2016) (8)
Chapter 19 – Immune-based tests for tuberculosis (2009) (8)
Validated methods for identifying tuberculosis patients in health administrative databases: systematic review. (2017) (8)
Highlights of the new 7th edition of the Canadian Tuberculosis Standards. (2014) (7)
Quantifying the rates of late reactivation tuberculosis: a systematic review. (2021) (7)
Solutions to improve the latent tuberculosis Cascade of Care in Ghana: a longitudinal impact assessment (2020) (7)
Asthma phenotypes based on health services use for allergic diseases in a province-wide birth cohort. (2019) (7)
The mTST – An mHealth approach for training and quality assurance of tuberculin skin test administration and reading (2019) (7)
Conhecimento e percepção de médicos e enfermeiros em três capitais brasileiras com alta incidência de tuberculose a respeito da transmissão e prevenção da doença (2018) (7)
Serum lipids as biomarkers for therapeutic monitoring of latent tuberculosis infection (2013) (7)
Effect of improving the quality of radiographic interpretation on the ability to predict pulmonary tuberculosis relapse. (2010) (7)
Yield of casual contact investigation by the hour. (2003) (6)
Using a quality improvement approach to improve care for latent tuberculosis infection (2018) (6)
Adequacy of Serial Self-performed SARS-CoV-2 Rapid Antigen Detection Testing for Longitudinal Mass Screening in the Workplace (2022) (6)
Mycobacterium tuberculosis transmission over an 11-year period in a low-incidence, urban setting. (2012) (6)
Microcolony culture techniques for tuberculosis diagnosis: a systematic review [Review article]. (2012) (6)
Treatment of latent TB: first do no harm (2011) (6)
Recommendations on Interferon Gamma Release Assaysfor the Diagnosis of Latent Tuberculosis Infection-2010 Update: An Advisory Committee Statement (ACS) Canadian Tuberculosis Committee (CTC)*†. (2010) (5)
Molecular methods for tuberculosis trials: time for whole-genome sequencing? (2013) (5)
New short regimens for latent tuberculosis treatment: safety first! (2018) (5)
Sputum induction for diagnosis of pulmonary tuberculosis: ready for prime time? (2006) (5)
Global survey of national tuberculosis drug policies. (2011) (5)
Knowledge and perceptions of tuberculosis transmission and prevention among physicians and nurses in three Brazilian capitals with high incidence of tuberculosis (2018) (5)
Changes in treatment for multidrug-resistant tuberculosis according to national income (2020) (4)
A qualitative meta-synthesis of facilitators and barriers to tuberculosis diagnosis and treatment in Nigeria (2020) (4)
Putting numbers on the End TB Strategy-an impossible dream? (2016) (4)
Tuberculosis preventive treatment in people living with HIV—Is the glass half empty or half full? (2021) (4)
Occupation-Related Respiratory Infections Revisited (2010) (4)
A public health approach to increase treatment of latent TB among household contacts in Brazil. (2020) (4)
Fixed Dose Combination Anti-tuberculosis Therapy: A Systematic Review and Meta-Analysis (2013) (4)
TB preventive treatment in high- and intermediate-incidence countries: research needs for scale-up. (2021) (4)
Which Countries Are Most Likely To Benefit from Highly Specific IGRAs? Findings from the World Atlas of BCG Policies and Practices. (2009) (4)
Finding the right dose of rifampicin, and the right dose of optimism. (2017) (4)
Rates and timeliness of treatment initiation among drug-resistant tuberculosis patients in Nigeria- A retrospective cohort study (2019) (4)
Understanding the gaps in DR-TB care cascade in Nigeria: A sequential mixed-method study (2020) (4)
Outcome evaluation findings from a pilot injury prevention project in the meat industry (1998) (4)
Evaluating new diagnostic tests in the field – are we doing it right? (2010) (3)
Correction: Commercial Serological Antibody Detection Tests for the Diagnosis of Pulmonary Tuberculosis: A Systematic Review (2007) (3)
Individualized Treatment Duration in Tuberculosis Treatment: Precision versus Simplicity (2021) (3)
Prevalence of Tuberculin Skin Test Reactions Among Prison Workers (1997) (3)
Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria (2022) (3)
A systematic review of commercial serological antibody detection tests for the diagnosis of extrapulmonary tuberculosis. (2007) (3)
Chapter 4: Diagnosis of tuberculosis infection (2022) (3)
Issues in the Management of Contacts of Patients with Active Pulmonary Tuberculosis (1997) (3)
Can BCG be useful to mitigate the COVID-19 pandemic? A Canadian perspective (2020) (3)
Hammering the point home: serologic testing costs more and harms more patients than other strategies for the diagnosis of active tuberculosis in India (2011) (3)
In women with suspected TB, brief sputum-submission instruction improved sampling quality and TB detection (2008) (3)
Effectiveness Of Pre-Immigration Screening And Post-Arrival Surveillance To Detect Active And Latent Tuberculosis In The Foreign Born: A Systematic Review And Meta-Analysis (2012) (3)
Four months of rifampicin monotherapy for latent tuberculosis infection in children (2021) (3)
Estimating treatment importance in multidrug‐resistant tuberculosis using Targeted Learning: An observational individual patient data network meta‐analysis (2019) (3)
Systematic Testing for SARS-CoV-2 Infection Among Essential Workers in Montreal, Canada: A Prospective Observational and Cost Assessment Study (2021) (2)
Multidrug-resistant tuberculosis – Authors' reply (2019) (2)
Risk of latent and active tuberculosis infection in travellers: a systematic review and meta-analysis. (2020) (2)
An Interactive Excel File to Estimate Costs of Expanded Testing for COVID-19 by RT-PCR and/or Serologic Tests (2020) (2)
WHO target product profiles for TB preventive treatment (2022) (2)
Evaluating the performance of propensity score matching based approaches in individual patient data meta-analysis (2021) (2)
Effectiveness of germicidal ultraviolet light to inactivate coronaviruses on personal protective equipment to reduce nosocomial transmission (2021) (2)
Finishing what they started: when do researchers' responsibilities end? (2015) (2)
Treating Active Tuberculosis In HIV Co-infected Patients: A Systematic Review And Meta-analysis (2010) (2)
Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis. (2023) (2)
Clinical interpretation of tests for latent tuberculosis infection (2008) (2)
Triage of Persons With Tuberculosis Symptoms Using Artificial Intelligence–Based Chest Radiograph Interpretation: A Cost-Effectiveness Analysis (2021) (2)
Microbial Contamination in Airplane Cabins:Health Effects and Remediation (2005) (2)
Mycobacterium tuberculosis infection and disease in healthcare workers in a tertiary referral hospital in Bandung, Indonesia (2022) (2)
Tuberculosis active case-finding: looking for cases in all the right places? (2021) (2)
New Tests for the Diagnosis of Latent Tuberculosis Infection (2007) (2)
Active tuberculosis case finding-do we have the right tool? (2016) (2)
Chapter 8: Drug-resistant tuberculosis (2022) (2)
Acceptability, feasibility, and impact of a pilot tuberculosis literacy and treatment counselling intervention: a mixed methods study (2021) (2)
Interferon-γ Release Assays For TB Screening Of Healthcare Workers: A Systematic Review (2010) (2)
What’s Next for the Standard Short-Course Regimen for Treatment of Multidrug-Resistant Tuberculosis (2019) (2)
Chapter 6: Tuberculosis preventive treatment in adults (2022) (2)
Modeling treatment effect modification in multidrug-resistant tuberculosis in an individual patientdata meta-analysis (2021) (2)
Intestinal dysbiosis compromises alveolar macrophage immunity to Mycobacterium tuberculosis (2019) (1)
Factors associated with delayed diagnosis of pulmonary tuberculosis in the state of Rio de Janeiro, Brazil* Fatores associados ao atraso no diagnóstico da tuberculose pulmonar no estado do Rio de Janeiro (2011) (1)
Safety of prolonged treatment with bedaquiline in programmatic conditions (2022) (1)
Comparing cost-effectiveness of standardized TB treatments given varying drug-resistance (2013) (1)
Clinical Phenotypic Features Of East African Indian Lineage Strains Of Mycobacterium Tuberculosis (2010) (1)
Canadian Tuberculosis Standards 8th edition: What’s new? And what’s next? (2022) (1)
Anemia with elevation of growth differentiation factor-15 level in linezolid treated multidrug-resistant tuberculosis: Case series of three patients (2022) (1)
Improved Diagnostic Evaluation of Suspected Tuberculosis : Editorial comment (2008) (1)
PD45 - BCG vaccination and childhood asthma: preliminary results from the Québec Birth Cohort on Immunity and Health (2014) (1)
Ease and equity of access to free DR-TB services in Nigeria- a qualitative analysis of policies, structures and processes (2020) (1)
Rifampin vs. Isoniazid for Treatment of Latent Tuberculosis: A Cost-Effectiveness Analysis Based on a Multicenter Clinical Trial. (2009) (1)
Using MODS And/or TLA Techniques For Active Tuberculosis Diagnosis: A Systematic Review And Meta-Analysis (2010) (1)
Contact investigation of a case of pulmonary and laryngeal tuberculosis. (2003) (1)
Testing and Treating Mycobacterium tuberculosis Infection. (2022) (1)
Systematic on-site testing for SARS-CoV-2 infection among asymptomatic essential workers in Montréal, Canada: a prospective observational and cost-assessment study (2022) (1)
High-dose rifamycins in the treatment of TB: a systematic review and meta-analysis (2022) (1)
Prevention of TB in areas of high incidence (2012) (1)
Scaling up investigation and treatment of household contacts of tuberculosis patients in Brazil: a cost-effectiveness and budget impact analysis (2022) (1)
Reply to van Deun and Decroo. (2020) (1)
Tuberculosis infection control measures and knowledge in primary health centres in Bandung, Indonesia (2021) (1)
Effects of programmatic interventions to improve the management of latent tuberculosis: a follow up study up to five months after implementation (2020) (1)
Tuberculosis crosses borders [The Eddie O'Brien Lecture]. (2000) (0)
A model was sensitive but not specific for screening for tuberculosis in contact patients (2008) (0)
Implementing the 4R and 9H regimens for TB preventive treatment in Indonesia (2022) (0)
Experiences with latent TB cascade of care strengthening for household contacts in Calgary, Canada. (2021) (0)
Low Body Mass Index at Treatment Initiation and Rifampicin-Resistant Tuberculosis Treatment Outcomes: An Individual Participant Data Meta-Analysis. (2022) (0)
Build back better: Advances in tuberculosis research in Canada & globally in 2020 (2021) (0)
Fatores associados ao atraso no diagnóstico da tuberculose pulmonar no estado do Rio de Janeiro* Factors associated with delayed diagnosis of pulmonary tuberculosis in the state of Rio de Janeiro, Brazil (2011) (0)
GeneXpert or chest-X-ray or tuberculin skin testing for household contact assessment (GXT): protocol for a cluster-randomized trial (2022) (0)
Side effects of antituberculosis drugs. Authors' reply (2004) (0)
Author's response to: Administrative database: validity of recording vs. validity of diagnosis (2006) (0)
Changes in Treatment Modalities and Outcomes for Multidrug-Resistant Tuberculosis from 2001 to 2015 (2020) (0)
What makes a score a winner? (2019) (0)
THE EFFECTIVENESS OF A PUBLIC HEALTH INTERVENTION UPON THE SCREENING FOR LATENT TUBERCULOSIS INFECTION AMONG HOUSEHOLD CONTACTS IN CENTRAL VIETNAM (2019) (0)
Mycobacterium tuberculosis Beijing strains in an immigrant-receiving country: an emerging public health threat? (2011) (0)
REDUCING POTENTIALLY INFECTIOUS BIOAEROSOLS DURING SPUTUM INDUCTION (2018) (0)
International Journal of Life science and Pharma Research Tuberculosis the Lernaean Hydra of 21st Century - A Post Covid Update on the Indian Scenario (2022) (0)
Is Rifampin a Safer Alternative for Latent Tuberculosis Infection (2009) (0)
Advances in tuberculosis in 2019 in Canada and globally (2020) (0)
Looking for TB in the sky: money well spent? (2014) (0)
RE: Responsible use of rifampin for the treatment of latent tuberculosis infection (2019) (0)
Mycobacterium tuberculosis as a Cause of Community-Acquired Pneumonia (2002) (0)
Microorganisms and building-related illnesses. (2001) (0)
Side effects of antituberculosis therapy. Authors' reply (2004) (0)
Screening for Latent Tuberculosis Infection. (2023) (0)
AEROANTIGENS IN OFFICE BUILDING WORKERS. AUTHORS' REPLY (1998) (0)
No evidence of increased risk of acquired rifampin resistance (2019) (0)
A Systematic Review and Meta-Analysis of Tuberculous Preventative Therapy Adverse Events. (2023) (0)
tandardised shorter regimens versus individualised longer regimens for multidrug-resistant tuberculosis (2020) (0)
Supporting Information for “Estimating treatment importance in multidrug-resistant tuberculosis using Targeted Learning: an observational individual patient data network meta-analysis” (2019) (0)
Testing and Scaling Interventions to Improve the Tuberculosis Infection Care Cascade. (2022) (0)
Factors Associated with Discontinuation of Tuberculosis Preventive Treatment: Post-Hoc Analysis of Two Randomized Controlled Trials. (2023) (0)
Deep Learning-Based A.I. Software for Chest X-Ray Analysis to Detect Microbiologically-Confirmed Tuberculosis: A Prospective Study of Diagnostic Accuracy (2020) (0)
Long-term Healthcare Utilization & Chronic Medication Use Of Former Premature Infants With Bronchopulmonary Dysplasia (2010) (0)
Management of latent tuberculosis infection in immigrants. (2003) (0)
Assessing the diagnostic performance of new commercial IGRAs for Mycobacterium tuberculosis infection: a systematic review and meta-analysis. (2023) (0)
Advances in Tuberculosis Research in the Past 10 Years: Solutions for a Global Problem (2020) (0)
From the authors: (2011) (0)
Reply to: "ATS/CDC/ERS/IDSA Clinical Practice Guidelines for Treatment of Drug-resistant TB: A Two-edged Sword?" (2020) (0)
Book Review Tuberculosis: Current concepts and treatment Second edition. Edited by Lloyd N. Friedman. 518 pp., illustrated. Boca Raton, Fla., CRC Press, 2000. $99.95. 0-8493-1565-4 (2000) (0)
THORAXJNL143180 62..70 (0)
Correction to: Reply to van Deun and Decroo. (2022) (0)
Reply to Wang and Zhang. (2015) (0)
Treatment Outcomes 24 Months after Initiating Short Bedaquiline- or Injectable-Containing Rifampicin-Resistant Tuberculosis Treatment Regimens: A Retrospective Cohort Study in South Africa (2021) (0)
Patterns and characteristics of TB among key risk groups in Canada, 1993-2018. (2022) (0)
Estimating Health system costs related to the LTBI Cascade of Care (2017) (0)
Acknowledging the Burden of Nosocomial COVID-19: Results from a Multi-Centre Retrospective Observational Study of 2518 Adults Hospitalised Across the Nation of Wales (2021) (0)
months isoniazid for latent TB randomised trial of 4 ? months rifampin or adverse events on health system costs in a Impact of treatment completion , intolerance and (0)
Notes from the field--TB control 'sound bites'. (1997) (0)
Conflict of Interest Statement: Neither author has a financial relationship with a commercial entity that has an interest in the subject of this manuscript. (2008) (0)
Four months of rifampicin for tuberculosis prevention treatment in children. (2022) (0)
Outcomes for multidrug-resistant tuberculosis patients with and without resistance to fluoroquinolones and second-line injectable drugs: A meta-analysis of individual patient data (2012) (0)
High dose rifampin for 2 months vs standard dose rifampin for 4 months, to treat TB infection: Protocol of a 3-arm randomized trial (2R2) (2023) (0)
Tuberculosis Treatment Costs for Patients under Supervised Treatment in Rio de Janeiro, Brazil. (2009) (0)
Standardized Regimens and the Emergence of Multidrug-resistant Tuberculosis (2009) (0)
Using other people's graphs--what should be acknowledged? (2001) (0)
Accuracy of Cytological Vs Histological Specimens for Assessment of Programmed Death-ligand 1 Expression in Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis (2023) (0)
Isoniazid-resistant tuberculosis treatment with first-line drugs-Author reply. (2017) (0)
ASTHMA / CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) STREAM THE INTERACTION OF BODY MASS INDEX (BMI) AND MEDICATION ADHERENCE ON ASTHMA CONTROL A Breath of Fresh Air Abstracts from the 1st Canadian Respiratory Conference (2016) (0)
Mortality in Adults with MDR-TB and HIV by ART and TB Drug Use: Individual Patient Data Meta-Analysis (2020) (0)
ABSTRACT WITHDRAWN (2019) (0)
Review: heterogeneous studies show that nucleic acid amplification tests accurately rule in but do not rule out TB (2007) (0)
Current Options in Treatment and Issues in Tuberculosis Care in Low- and Middle-Income Countries (2017) (0)
Reply to Chang and Yew (2020) (0)
Reply to Dobler. (2017) (0)
PREVALENCE OF LATENT TUBERCULOSIS AMONG HOUSEHOLD CONTACTS OF PATIENTS WITH MULTIDRUG‐RESISTANT TUBERCULOSIS IN VIETNAM (2019) (0)
University of Groningen Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes (2012) (0)
Association of smoking and alcohol use with rifampin-resistant TB treatment outcomes. (2023) (0)
Tuberculosis research in resource poor countries and in Canada : current problems and future priorities (1995) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Dick Menzies?

Dick Menzies is affiliated with the following schools:

Dick Menzies's Academic­Influence.com Rankings